Position in LFCR
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$781
-$290 QoQ
Shares Held
210
+60.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FIFTH THIRD BANCORP holds $144,698,835 across 36 Drug Manufacturers - Specialty & Generic names. LFCR ranks #35 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
164,978 | $97,828,654 | |
| 2 | ZTS |
Zoetis Inc.
|
141,537 | $16,731,088 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
318,927 | $7,631,923 | |
| 4 | VTRS |
Viatris Inc
|
422,971 | $5,714,338 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
27,393 | $3,608,753 | |
| 6 | HLN |
Haleon plc
|
217,156 | $2,173,731 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
34,137 | $1,764,541 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
29,052 | $1,721,912 |
All Filings in LFCR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $781 | 210 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $1,071 | 131 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $964 | 131 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $1,364 | 168 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $471 | 67 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $965 | 130 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $1,084 | 220 | Shares | Defined | 2024-10-17 | |
| 2020-06-30 | $7,960 | 1,000 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $8,690 | 1,000 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||